Business Wire

Data from Incyte’s Oncology Portfolio to be Featured at the 2019 ESMO Congress

Share

Incyte (Nasdaq:INCY) announces that abstracts highlighting data from its oncology portfolio will be presented at the upcoming European Society for Medical Oncology (ESMO) 2019 Congress taking place in Barcelona, Spain from September 27-October 1, 2019.

Results from FIGHT-202, a Phase 2 study of pemigatinib as a second-line treatment for patients with advanced/metastatic or surgically unresectable cholangiocarcinoma, including updated safety and efficacy data in patients with FGFR2 fusions or rearrangements, as well as genomic profiling and correlations with clinical outcomes will be presented. Results from the Phase 1 study of INCB001158, an arginase inhibitor being developed with Calithera Biosciences, alone and in combination with pembrolizumab as a treatment for advanced or metastatic solid tumors, will also be presented.

“Incyte is committed to advancing treatments that have the potential to address areas of high unmet need and we look forward to sharing data on our investigational therapies with the oncology community at ESMO 2019,” said Steven Stein, M.D., Chief Medical Officer, Incyte. “Data from the Phase 2 FIGHT-202 study assessing pemigatinib as a potential treatment for cholangiocarcinoma are encouraging and may represent an important step forward for patients in urgent need of effective treatment options.”

Abstracts will be available on the ESMO Congress website at https://www.esmo.org/Conferences/ESMO-Congress-2019.

Oral Presentations:

FIGHT-202: a Phase 2 study of pemigatinib in patients (pts) with previously treated locally advanced or metastatic cholangiocarcinoma (CCA) (Abstract #2550, proffered paper session)

  • Friday, September 27, 2019 from 3:00 p.m. CEST to 3:15 p.m. CEST (9 a.m. ET to 9:15 a.m. ET) in Madrid Auditorium (Hall 2)

Phase 1 study of the arginase inhibitor INCB001158 (1158) alone and in combination with pembrolizumab (PEM) in patients (Pts) with advanced/metastatic (Adv/Met) solid tumors (Abstract #1621, oral abstract session)

  • Sunday, September 29, 2019 from 4:54 p.m. CEST to 5:06 p.m. CEST (10:54 a.m. ET to 11:06 a.m. ET) in Malaga Auditorium (Hall 5)

Poster Details:

Comprehensive genomic profiling and clinical outcomes in patients (pts) with fibroblast growth factor receptor rearrangement-positive (FGFR2+) cholangiocarcinoma (CCA) treated with pemigatinib in the FIGHT-202 trial (Abstract #2078, poster session)

  • Sunday, September 29, 2019 from 12:00 p.m. CEST to 1:00 p.m. CEST (6:00 a.m. ET to 7:00 a.m. ET) in Poster Area (Hall 4)

Full session details and data presentation listings for ESMO 2019 can be found at: https://cslide.ctimeetingtech.com/esmo2019/attendee.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company’s website at www.incyte.com.

Follow @Incyte on Twitter at https://twitter.com/Incyte.

Forward-Looking Statements

Except for the historical information set forth herein, the matters set forth in this press release, including statements regarding the presentation of data from the Company’s ongoing clinical development programs for pemigatinib and an arginase inhibitor as monotherapy and in combination with pembrolizumab and the potential of such programs, including the potential for pemigatinib to treat cholangiocarcinoma, contain predictions, estimates and other forward-looking statements.

These forward-looking statements are based on the Company’s current expectations and subject to risks and uncertainties that may cause actual results to differ materially, including unanticipated developments in and risks related to: unanticipated delays; further research and development and the results of clinical trials possibly being unsuccessful or insufficient to meet applicable regulatory standards or warrant continued development; the ability to enroll sufficient numbers of subjects in clinical trials; determinations made by the FDA; the Company’s dependence on its relationships with its collaboration partners; the efficacy or safety of the Company’s products and the products of the Company’s collaboration partners; the acceptance of the Company’s products and the products of the Company’s collaboration partners in the marketplace; market competition; sales, marketing, manufacturing and distribution requirements; greater than expected expenses; expenses relating to litigation or strategic activities; and other risks detailed from time to time in the Company’s reports filed with the Securities and Exchange Commission, including its Form 10-Q for the quarter ended June 30, 2019. The Company disclaims any intent or obligation to update these forward-looking statements.

Contact information

Incyte Contacts
Media
Catalina Loveman
+1 302 498 6171
cloveman@incyte.com

Investors
Michael Booth, DPhil
+1 302 498 5914
mbooth@incyte.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Zynga Enters Into Agreement to Acquire Istanbul-based Rollic, One of the Fastest Growing Hyper-Casual Mobile Game Companies5.8.2020 23:06:00 EESTPress release

Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, today announced it has entered into an agreement to acquire Istanbul-based Rollic, a mobile games developer and publisher with an exciting portfolio of popular hyper-casual games that have been downloaded more than 250 million times. With this acquisition, Zynga enters the hyper-casual market – one of the largest and fastest growing gaming categories on mobile – and adds a highly talented team and an extensive network of external developers. Rollic will meaningfully increase our audience and grow our advertising business. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200805005030/en/ Zynga Enters Into Agreement to Acquire Istanbul-based Rollic (Graphic: Business Wire) Founded in December 2018 by Burak Vardal, Deniz Basaran and Mehmet Can Yavuz, Rollic is a hyper-casual publisher and game developer based in Istanbul, Turkey. Eight of Rollic’s games have

Zynga Announces Second Quarter 2020 Financial Results5.8.2020 23:05:00 EESTPress release

Zynga Inc. (Nasdaq: ZNGA) today released financial results for its second quarter ended June 30, 2020 by posting management’s Q2 2020 Quarterly Earnings Letter to its Investor Relations website. Please see the attached Quarterly Earnings Letter or visit http://investor.zynga.com/financial-information/quarterly-results to access the letter. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200805005297/en/ “We delivered tremendous results in Q2, achieving our highest quarterly revenue and bookings and generating Zynga’s best quarterly operating cash flow in more than eight years. We also executed our transformational acquisition of Peak and are now entering Q3 with eight forever franchises, adding significant scale to our live services foundation,” said Frank Gibeau, Chief Executive Officer of Zynga. “Additionally, we have entered into an agreement to acquire Istanbul-based Rollic, developer and publisher of a portfolio of popul

Rimini Street Announces Fiscal Second Quarter 2020 Financial Results5.8.2020 23:05:00 EESTPress release

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today announced results for the second quarter ended June 30, 2020. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200805005274/en/ Rimini Street Announces Fiscal Second Quarter 2020 Financial Results (Graphic: Business Wire) “For the second quarter, we continued to execute well against our strategic growth plan. We achieved record quarterly revenue, within guidance, delivered quarterly gross margin above guidance, maintained a revenue retention rate over 90 percent, produced another quarter of net income, generated $17.9 million of operating cash flow and further strengthened the balance sheet with record total cash of $73.0 million at quarter end,” stated Seth A. Ravin , Rimini Street co-founder, CEO and chairman of the bo

Rimini Street Further Speeds Software Issue Resolution with Shortened Guaranteed Response Times5.8.2020 20:00:00 EESTPress release

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of business software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today announced that it has further enhanced its industry-leading service response guarantee for clients, at no additional fee. The new service level agreement shortens guaranteed response times for critical Priority 1 cases from 15 minutes to 10 minutes and for serious Priority 2 cases from 30 minutes to 15 minutes – further speeding software issue resolution. Rimini Street had previously shortened guaranteed response times for Priority 1 cases from 30 minutes to 15 minutes and Priority 2 cases from 2 hours to 30 minutes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200805005802/en/ Rimini Street Further Speeds Software Issue Resolution with Shortened Guaranteed Response Times (Photo: Business Wire) Committed to Better Clie

Verimatrix Debuts Industry’s First Elastic Anti-Tamper Technology to Protect Bitcode-Enabled iOS Apps5.8.2020 18:35:00 EESTPress release

Regulatory News: Verimatrix (Paris:VMX) (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced unprecedented new protection for Bitcode-enabled iOS applications. Publishing an app to Apple’s App Store with Bitcode enabled allows Apple to optimize the app’s code for each target device. For the first time, developers are now able to provide much-needed anti-tamper protections for the fast-growing Bitcode iOS market. Through a new, Elastic Anti-Tamper feature, Verimatrix’s family of award-winning Application Shielding solutions now feature powerful technology that compares application actions to that of when it was first launched by the user. The ongoing comparison identifies potentially dangerous tampering by cybercriminals and offers unmatched security for Bitcode apps and their associated data. Until now, it was a challenge to apply anti-tamper technology to Bitcode since Apple, and not the developer, creates the final fo

RDC Wins Award in Celent KYC Report5.8.2020 18:00:00 EESTPress release

Regulatory DataCorp (RDC) has been recognized in a new report from Celent that profiles vendors of Know Your Customer (KYC) systems. RDC, which Moody’s acquired in January, won the 2020 xCelent Customer Base award for KYC Systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200805005308/en/ (Graphic: Business Wire) The number of live customers using its system, and the geographic footprint and business sectors of its client base are among the factors that contributed to RDC earning this award. RDC combines forward-looking technology with an expansive proprietary risk-relevant dataset to deliver best-in-class customer screening solutions. Organizations around the world employ RDC solutions when onboarding new customers, for their ongoing KYC and AML compliance and anti-bribery and corruption due diligence, and for assessing and managing their vendor risk. “The ability to assess the risk status of new customers—as well as c

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom